MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
Summary: Activation of mitogenic signaling pathways is a common oncogenic driver of many solid tumors including lung cancer. Although activating mutations in the mitogen-activated protein kinase (MAPK) pathway are prevalent in non-small cell lung cancers, MAPK pathway activity, counterintuitively, i...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/408084487e324b9abf64eba52e8ffc2a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|